Journal of Clinical Psychopharmacology

Papers
(The TQCC of Journal of Clinical Psychopharmacology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Trazodone and Mianserin for Delirium44
Polypharmacy Among Patients With Major Depressive Disorder and Co-occurring Substance Use Disorders in a Psychiatric Hospital Setting34
The Treatment of Iatrogenic Anorgasmia in a Male Patient on Clozapine for Treatment-Resistant Schizophrenia33
Question29
Hodgkin Lymphoma in Patients Receiving Clozapine Treatment28
Dysphagia to Liquids Only Associated With Olanzapine22
Beneficial Effect of Quetiapine on Sleep, Anxiety, Depression and Myalgia Symptoms in a Patient With Post–COVID-19 Condition20
Clozapine-Associated Myocarditis in a Patient With Poor Metabolism During Fast Titration20
Transitioning From a Standard Low-Dose to a Rapid Low-Dose Buprenorphine Initiation in a Hospital Setting—A Case Report19
Use of Suvorexant and Antipsychotics in the Treatment of Delirium After Infectious Diseases19
Comparison of Weight-Based Valproic Acid Dosing in Treatment of Mental Illness Among Obese and Nonobese Patients16
Plasma Concentrations of Tranylcypromine in Depressed Patients With Chronic Kidney Disease15
Valbenazine, Fluphenazine, and Possible Neuroleptic Malignant Syndrome in a 58-Year-Old Woman14
Erratum: What Is the Current State of Evidence Regarding Any Mood-Improving Properties of GLP-1 Receptor Agonists, and Are Psychiatrists Prescribing Them?13
Author Index 202213
Postinjection Syndrome After Paliperidone?12
Clozapine Use Among Individuals With Schizophrenia Occurring on the Background of Intellectual Disability and Rare Genetic Variation12
Possibly Misleading Pharmaceutical Advertising On TV12
Pharmacokinetic-Interactions of BI 425809, a Novel Glycine Transporter 1 Inhibitor, With Cytochrome P450 and P-Glycoprotein Substrates12
Better Approaches to Derisking Psychiatric Drug Development are Needed, Not New Funding Mechanisms12
Treatment of Cannabis Hyperemesis Syndrome Using Haloperidol in a Pregnant Patient11
Drug-Associated Liver Injury Related to Antipsychotics11
Recognition of Clozapine-Associated Eosinopenia in Patients With Treatment-Resistant Schizophrenia11
Suicidal Ideation and Self-harming Thoughts With Valbenazine Use10
Time to Rehospitalization for Different Oral Risperidone Dosing Frequencies in Patients With Schizophrenia10
Prediction of Corresponding Dose of Transdermal Blonanserin to Oral Dose Based on Dopamine D2 Receptor Occupancy10
Mild Neutropenia After Suicide Attempt With 900 Milligrams Intake of Mirtazapine10
Late-Onset Polyserositis Emerging During Long-Term Clozapine Treatment and Persisting After Clozapine Discontinuation10
Celebrating 70 Years of the First Publication on Antipsychotic Treatment in North America by Heinz E. Lehmann and Gorman E. Hanrahan: Would Their Methodology Still Be Conceivable?10
Duloxetine-Associated Erosive Gastritis and Gastroesophageal Reflux10
Mirtazapine as a Treatment for Adolescent Depression and PTSD in Juvenile Detention Settings10
Thoughts on the Value of Case Series in the Literature10
Mood Swings and Irritability in a Patient With Cystic Fibrosis on Elexacaftor-Tezacaftor-Ivacaftor Therapy9
Treatment of Acute Intermittent Porphyria–Associated Anxiety Disorder With Gabapentin9
Postpartum Depression and Antibiotics Overuse in Pakistan: Exploring a Potential Nexus9
SALUTE TO OUR REVIEWERS9
Effect of Valproate Coprescription on Clozapine Pharmacokinetics in Clinical Practice9
Effect of Cigarette Smoking on Clozapine Dose and on Plasma Clozapine and N-Desmethylclozapine (Norclozapine) Concentrations in Clinical Practice: Erratum9
Neuroleptic Malignant Syndrome Associated With Lurasidone9
Zopiclone Discontinuation–Associated Transient Sleepwalking Behavior9
Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders8
Clinical and Demographic Predictors of Early Clozapine Discontinuation Across Mood and Psychotic Disorders8
Prolonged Agranulocytosis Despite a Granulocyte Colony-Stimulating Factor Treatment During Clozapine Treatment8
Plasma Clozapine and N-Desmethylclozapine (Norclozapine) Concentrations and the Clozapine/Norclozapine Ratio8
Clozapine Once-Daily Versus Divided Dosing Regimen8
Factors Associated With Poor Response to Clozapine in Schizophrenia8
A Case of Akathisia After Administration of a Very Low Dose of Mirtazapine7
Successful Management of ECT-Resistant Interictal Psychosis With Clozapine7
Letter to the Editors in Response to: Flanagan RJ, Hunter S, Obee S, Reeves S. Plasma Clozapine and Norclozapine After Use of Either Crushed Tablets or Suspension Compared With Tablets7
Long-Term Course of Illness With Rapid-Cycling Bipolar Disorder7
The Clinical and Economic Burden of Tardive Dyskinesia in Israel7
Aripiprazole as First-Line Therapy for Late-Life Depression7
Journal of Clinical Psychopharmacology Updates7
Use of Risperidone Long-Acting Injection in the Treatment of Anorexia Nervosa: A Case Report7
Successful Treatment of Inappropriate Sexual Behavior and Disinhibition in Dementia With Paroxetine7
Inverse Association Between Persistence With Antidepressant Medication and Onset of Chronic Pain in Patients With Depression7
Severe Panic Disorder After Vaccination With the Pfizer-BioNTech Vaccine7
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE1046
Oculogyric Crisis Associated With Clozapine: Case Report and Review of Literature6
COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants—A Scoping Review6
Aripiprazole-Associated QT Prolongation in a Healthy Study Volunteer6
Mania Associated With Cariprazine6
Untreated Mental Illness Has Created a National Tragedy6
Question6
A Withdrawal Syndrome After a Switch of Phenibut to Another γ-Aminobutyric Acid Agonist6
Postinjection Delirium/Sedation Syndrome After Paliperidone Palmitate Injection in a Bipolar Affective Disorder Patient6
Olanzapine-Associated Hyperbilirubinemia in an Adolescent With Autistic Spectrum Disorder Comorbid With Schizophrenia6
Plasma Clozapine in Treatment Refractory Schizophrenia6
A Manic Episode With Psychotic Features Associated With Levetiracetam6
Use of Clozapine in Pregnancy6
Clozapine- and Lithium-Associated Myoclonus6
A System for Rapidly Yet Rigorously Evaluating the Quality of Randomized Controlled Trials6
Pharmacokinetics of Ketamine Transfer Into Human Milk5
Valproic Acid–Associated Hyperammonemia5
A Case of Hyperpyrexia Associated With Risperidone Microspheres for Injection (II)5
Alpha Lipoic Acid for Schizophrenia5
Incorporating Real-World Treatment Data Into Clozapine's Product Label5
Clozapine Associated Periorbital Edema in First Episode Psychosis5
Clozapine-Associated Agranulocytosis5
Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs5
Mania-Like Reaction Secondary to Sodium Oxybate5
Subject Index 20225
Lithium-Associated Nephrogenic Diabetes Insipidus or Catatonic Stereotypical Drinking?5
Therapeutic Drug Monitoring of Paliperidone in Patients With Schizophrenia in Taiwan5
The Association Between Mood Stabilizers, Sleep Quality, and Functioning in Patients With Remitted Bipolar Disorder5
Author Index 20245
Resolution of Catatonia With Cariprazine—A Case Report5
Dysphagia From Long-Term Olanzapine Use5
Haloperidol-Induced Brugada-Pattern Electrocardiogram—A Case Report and a Review of the Literature5
Atomoxetine Associated Activation Syndrome in Adolescent Patients With ADHD5
Use of Sublingual Atropine Drops in Clozapine-Associated Sialorrhea in an Adolescent Patient5
Sleep Quality After Quetiapine Augmentation in Patients With Treatment-Resistant Depression and Personality Disorders5
Clozapine Use in Down Syndrome5
Liraglutide in Obese or Overweight Individuals With Stable Bipolar Disorder5
Reversible Valproic Acid–Associated Cerebral Pseudoatrophy in a 53-Year-Old Male With Bipolar I Disorder4
The Potential Role of Fluvoxamine in Clozapine-Associated Constipation4
Combination of Long-Acting Injectable Antipsychotics in the Treatment of Psychiatric Disorders—A Systematic Review of the Literature and Case Series4
Hematological and Other Cancers in People Using Clozapine4
Positive Pyramidal Sign as an Unexpected Presentation in Antipsychotic-Induced Acute Dystonia4
Article Selected to Receive the Mitchell B. Balter Award for 20224
Efficacy of Brexpiprazole Combination Therapy on Anhedonia in a Case of Treatment Resistant Bipolar II Depression4
Seizure, Rhabdomyolysis, and Hypoglycemia in a Patient With Venlafaxine Poisoning4
The Need for Non-profit Psychiatric Drug Discovery and Development4
Neurotoxicity Related to Multidrug Association: A Case Report4
Topiramate-Associated Acute Bilateral Angle-Closure Glaucoma4
Exploring the Addictive Potential of Tranylcypromine4
Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use4
Differentiating Depressive Symptoms From Side Effects in Individuals With Major Depressive Disorder With Postpartum Onset4
Protracted Psychiatric Complications Including Psychosis in a Middle-Aged Man After COVID-19 Vaccination4
Can Quetiapine Prolong the Antidepressant Effect of Ketamine?4
Improving Result Turnaround Time as a Crucial Factor to Increasing Clozapine Therapeutic Drug Monitoring in Hospitalized Patients4
Response to Letter to the Editors From Prof D. Taylor4
Comparison of Psychiatric and Clinical Profiles Between People Who Use Synthetic Cathinones and Methamphetamine4
Lumbosacral Plexopathy in Clozapine Overdose: A Case Report4
You Shall Not Turn a Blind Eye to Intraocular Pressure4
At Last, a Nondopaminergic Agent for the Treatment of Schizophrenia: The Combination of Xanomeline and Trospium (Cobenfy)4
Clinical Phenotype of Tardive Dyskinesia in Bipolar Disorder4
Esketamine for Unipolar Major Depression With Psychotic Features4
Impact of Selective Serotonin-Reuptake Inhibitors in Hemorrhagic Risk in Anticoagulated Patients Taking Non–Vitamin K Antagonist Anticoagulants4
Reply: Misidentified Dopamine Agonists Undermine Investigation Into Aripiprazole Link With Impulse Control Disorders4
Fluoxetine and Sertraline Inhibit Height Growth and Growth Hormone Signaling During Puberty4
The Switch From Paliperidone Long-Acting Injectable 1- to 3-Monthly4
Methylphenidate-Associated Syncope4
Characterization of Extended-Release Lorazepam4
Combination With Long-Acting Injectable Antipsychotics and Utilization of Nonstandard Formulations as Compliance Enhancing Methods for Clozapine Users4
The Management of Very Early-Onset Schizophrenia With an Olanzapine and Amisulpride Combination3
How Does Drug Company Marketing Affect Physician Prescribing?3
Prophylactic Management of Women With Bipolar Disorder During Pregnancy and the Perinatal Period3
A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants3
Semaglutide Misuse in Atypical Anorexia Nervosa—A Case Report3
High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder3
Tardive Dyskinesia Suppressed With Ginkgo Biloba3
Paliperidone Extended Release Versus Olanzapine in Treatment-Resistant Schizophrenia3
Assessing Adherence to Clozapine3
The Potential Benefits of Chromium and Selenium Supplementation Across Psychiatric Disorders and Symptoms3
A First Trimester Exposure to Ketamine and Esketamine for Depression3
Panic Disorder Seeks More Specific Drugs for Treatment3
A Case of Acute Conditioned Dyspnea During Tracheostomy Weaning Treated Successfully With Adjunctive Mirtazapine3
Clonidine and Trihexyphenidyl in Clozapine-induced Hypersalivation3
Relapse of Tardive Dyskinesia Following Successful Treatment With Amantadine3
Detecting Anxious Distress, an Important Mood Specifier3
New Onset of Seizures and Psychosis in a Patient Who Is Coprescribed Atomoxetine and Bupropion3
Pramipexole as an Augmentation Strategy to Electroconvulsive Therapy in the Treatment of Bipolar Depression Complicated With Parkinsonism3
Health Alert: Microdose Products Leading to Acute Illness and Hospitalizations Across the United States3
Evaluating the Quality of Randomized Controlled Trials3
The Impact of Once Daily Dosing on Protein Binding of Clozapine and Norclozapine3
Growing Concerns Over Valproate Teratogenicity Present an Opportunity for Lithium3
Effects of Vortioxetine Versus Placebo on Cognition and Functional Capacity in Adults With Posttraumatic Stress Disorder: Erratum3
Preventive Effects of Ramelteon, Suvorexant, and Lemborexant on Delirium in Hospitalized Patients With Physical Disease3
Journal of Clinical Psychopharmacology Updates3
Impact of Prior Psychiatric Diagnoses on the Incidence of Dissociative Symptoms Associated With Analgesic Ketamine Infusions in a Surgical Intensive Care Unit3
Ketamine and Esketamine for Depression in Daily Practice3
Concentrations of Fluoxetine Enantiomers Decline During Pregnancy and Increase After Birth3
Second-Generation Antipsychotic Long-Acting Injection Reduced the Time of Restrictive Interventions in Patients With Schizophrenia3
A Potential Drug-Gene-Drug Interaction Between Cannabidiol, CYP2D6*4, and Fluoxetine3
Managing a Treatment-Resistant Schizophrenia Spectrum Disorder With a Hormonal Twist in a Female Patient3
Venlafaxine-Associated Rhabdomyolysis3
Journal of Clinical Psychopharmacology Updates3
Severe Alprazolam Withdrawal With Delirium and Psychosis3
Toxidrome of an Easily Obtainable Nootropic3
Recurrent Guaifenesin-Associated Nephrolithiasis Complicates Dextromethorphan Abuse3
Plasma Clozapine and Norclozapine After Use of Either Crushed Tablets or Suspension Compared With Tablets3
REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants3
0.12653994560242